ArticleBMC cancer2021

A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.

Salvatore Paiella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.